1 min read
Hims & Hers Launches Peptides+ With Up to Five Compounded Products
The offering follows an Oct. 28 HHS plan to temporarily allow compounding pharmacies to make six peptides.

Hims & Hers Health announced Wednesday, Nov. 18, that it had launched Peptides+, an offering with up to five products compounded in the United States.
The launch follows HHS's plan for temporary peptide compounding. Announced Oct. 28, the proposed interim policy would temporarily allow compounding pharmacies to make six peptides.